Can minocycline be a carbapenem sparing antibiotic? Current evidence.
Indian J Med Microbiol
;
2016 Oct-Dec; 34(4): 513-515
Artículo
en Inglés
| IMSEAR
| ID: sea-181118
ABSTRACT
With the increasing incidence of multidrug‑resistant organisms, there is a need for newer antibiotics. However, due to the lack of new antimicrobial agents, it is necessary to re‑evaluate the older agents like minocycline which is a second‑line antimicrobial agent. In this study, minocycline susceptibility testing was performed for 693 Escherichia coli, 316 Klebsiella spp. and 89 Acinetobacter spp. Among extended spectrum beta‑lactamase producing E. coli and Klebsiella spp. percentage susceptibility to minocycline were 76 and 85, respectively. Among the carbapenem resistant E. coli, Klebsiella spp. and Acinetobacter spp. minocycline susceptibility were 52%, 55% and 42%, respectively. Based on the susceptibility profile, minocycline can be considered for treatment of infections by multidrug‑resistant organisms.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Idioma:
Inglés
Revista:
Indian J Med Microbiol
Asunto de la revista:
Microbiology
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS